Hostile takeover: how tumours hijack pre-existing vascular environments to thrive

Journal of Pathology

Volumn 242, Issue 3, 2017, Pages 267-272

  Winkler, Frank ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

angiocentric growth; angiogenesis; perivascular niche; vascular co option

Indexed keywords

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; ARTICLE; DORMANCY; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT; VASCULAR TUMOR; VASCULARIZATION; CANCER STEM CELL; DISEASE COURSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY;

DISEASE PROGRESSION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 85020517220     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4904     Document Type: Article

References (64)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
2. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18: 884–901.
3. Osswald M, Jung E, Sahm F, et al. Brain tumour cells interconnect to a functional and resistant network. Nature 2015; 528: 93–98.
4. Karreman MA, Mercier L, Schieber NL, et al. Fast and precise targeting of single tumor cells in vivo by multimodal correlative microscopy. J Cell Sci 2016; 129: 444–456.
5. Ellenbroek SI, van Rheenen J. Imaging hallmarks of cancer in living mice. Nat Rev Cancer 2014; 14: 406–418.
6. Osswald M, Winkler F. Insights into cell-to-cell and cell-to-blood-vessel communications in the brain: in vivo multiphoton microscopy. Cell Tissue Res 2013; 352: 149–159.
7. Alexander S, Weigelin B, Winkler F, et al. Preclinical intravital microscopy of the tumour–stroma interface: invasion, metastasis, and therapy response. Curr Opin Cell Biol 2013; 25: 659–671.
8. Pezzella F, Pastorino U, Tagliabue E, et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997; 151: 1417–1423.
9. Pastorino U, Andreola S, Tagliabue E, et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 1997; 15: 2858–2865.
10. Sardari Nia P, Colpaert C, Blyweert B, et al. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer. Br J Cancer 2004; 91: 1293–1300.
11. Bridgeman VL, Vermeulen PB, Foo S, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. J Pathol 2017; 241: 362–374.
12. Szabo V, Bugyik E, Dezso K, et al. Mechanism of tumour vascularization in experimental lung metastases. J Pathol 2015; 235: 384–396.
13. Vermeulen PB, Colpaert C, Salgado R, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 2001; 195: 336–342.
14. Stessels F, Van den Eynden G, Van der Auwera I, et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 2004; 90: 1429–1436.
15. Frentzas S, Simoneau E, Bridgeman VL, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med 2016; 22: 1294–1302.
16. Kuczynski EA, Yin M, Bar-Zion A, et al. Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma. J Natl Cancer Inst 2016; 108: djw030.
17. Mandelcorn ED, Palestine AG, Dubovy S, et al. Vascular co-option in lung cancer metastatic to the eye after treatment with bevacizumab. J Ophthalmic Inflamm Infect 2010; 1: 35–38.
18. Dome B, Hendrix MJ, Paku S, et al. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007; 170: 1–15.
19. Jeong HS, Jones D, Liao S, et al. Investigation of the lack of angiogenesis in the formation of lymph node metastases. J Natl Cancer Inst 2015; 107: djv155.
20. Lim S, Hosaka K, Nakamura M, et al. Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis. Oncotarget 2016; 7: 38282–38291.
21. Bald T, Quast T, Landsberg J, et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014; 507: 109–113.
22. Winkler F, Kienast Y, Fuhrmann M, et al. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia 2009; 57: 1306–1315.
23. Baker GJ, Yadav VN, Motsch S, et al. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 2014; 16: 543–561.
24. Kienast Y, von Baumgarten L, Fuhrmann M, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 2010; 16: 116–122.
25. Valiente M, Obenauf AC, Jin X, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014; 156: 1002–1016.
26. Bentolila LA, Prakash R, Mihic-Probst D, et al. Imaging of angiotropism/vascular co-option in a murine model of brain melanoma: implications for melanoma progression along extravascular pathways. Sci Rep 2016; 6: 23834.
27. Bugyik E, Dezso K, Reiniger L, et al. Lack of angiogenesis in experimental brain metastases. J Neuropathol Exp Neurol 2011; 70: 979–991.
28. Carbonell WS, Ansorge O, Sibson N, et al. The vascular basement membrane as ‘soil’ in brain metastasis. PLoS One 2009; 4: e5857.
29. Leenders WP, Kusters B, Verrijp K, et al. Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res 2004; 10: 6222–6230.
30. di Tomaso E, Snuderl M, Kamoun WS, et al. Glioblastoma recurrence after cediranib therapy in patients: lack of ‘rebound’ revascularization as mode of escape. Cancer Res 2011; 71: 19–28.
31. Jain RK. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 2014; 26: 605–622.
32. Hu J, Bianchi F, Ferguson M, et al. Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene 2005; 24: 1212–1219.
33. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood–brain barrier. Nat Med 2013; 19: 1584–1596.
34. Yao Y, Chen ZL, Norris EH, et al. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 2014; 5: 3413.
35. Gautam J, Zhang X, Yao Y. The role of pericytic laminin in blood brain barrier integrity maintenance. Sci Rep 2016; 6: 36450.
36. Paku S, Lapis K. Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol 1993; 143: 926–936.
37. Montana V, Sontheimer H. Bradykinin promotes the chemotactic invasion of primary brain tumors. J Neurosci 2011; 31: 4858–4867.
38. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994–1998.
39. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–1186.
40. Butler JM, Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer 2010; 10: 138–146.
41. Oh M, Nor JE. The perivascular niche and self-renewal of stem cells. Front Physiol 2015; 6: article 367.
42. Winkler F. The brain metastatic niche. J Mol Med 2015; 93: 1213–1220.
43. Chen JY, Miyanishi M, Wang SK, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature 2016; 530: 223–227.
44. Acar M, Kocherlakota KS, Murphy MM, et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature 2015; 526: 126–130.
45. Tamplin OJ, Durand EM, Carr LA, et al. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell 2015; 160: 241–252.
46. Krause DS, Scadden DT. A hostel for the hostile: the bone marrow niche in hematologic neoplasms. Haematologica 2015; 100: 1376–1387.
47. Beck B, Driessens G, Goossens S, et al. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 2011; 478: 399–403.
48. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69–82.
49. Zhu G, Rankin SL, Larson JD, et al. PTEN signaling in the postnatal perivascular progenitor niche drives medulloblastoma formation. Cancer Res 2017; 77: 123–133.
50. Hambardzumyan D, Becher OJ, Rosenblum MK, et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 2008; 22: 436–448.
51. Goldman SA, Chen Z. Perivascular instruction of cell genesis and fate in the adult brain. Nat Neurosci 2011; 14: 1382–1389.
52. Charles N, Ozawa T, Squatrito M, et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 2010; 6: 141–152.
53. Lathia JD, Li M, Hall PE, et al. Laminin alpha 2 enables glioblastoma stem cell growth. Ann Neurol 2012; 72: 766–778.
54. Zhang Z, Dong Z, Lauxen IS, et al. Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res 2014; 74: 2869–2881.
55. Goss PE, Chambers AF. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 2010; 10: 871–877.
56. Ghajar CM, Peinado H, Mori H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 2013; 15: 807–817.
57. Naumov GN, Bender E, Zurakowski D, et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst 2006; 98: 316–325.
58. Indraccolo S, Stievano L, Minuzzo S, et al. Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. Proc Natl Acad Sci U S A 2006; 103: 4216–4221.
59. Indraccolo S, Minuzzo S, Masiero M, et al. Cross-talk between tumor and endothelial cells involving the Notch3–Dll4 interaction marks escape from tumor dormancy. Cancer Res 2009; 69: 1314–1323.
60. Paku S, Laszlo V, Dezso K, et al. The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization. J Pathol 2017; 241: 441–447.
61. Johansson A, Hamzah J, Ganss R. More than a scaffold: stromal modulation of tumor immunity. Biochim Biophys Acta 2016; 1865: 3–13.
62. Lewis CE, Harney AS, Pollard JW. The multifaceted role of perivascular macrophages in tumors. Cancer Cell 2016; 30: 18–25.
63. Brandenburg S, Muller A, Turkowski K, et al. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors. Acta Neuropathol 2016; 131: 365–378.
64. Bayerl SH, Niesner R, Cseresnyes Z, et al. Time lapse in vivo microscopy reveals distinct dynamics of microglia–tumor environment interactions – a new role for the tumor perivascular space as highway for trafficking microglia. Glia 2016; 64: 1210–1226.